Can Vitamin D reduce the need for SSRI by modulating serotonin synthesis? : a review of recent literature

Basit Öğe Kaydı
dc.contributor.authorBostan, Zekiye Zeynep
dc.contributor.authorBulut, Melike Sare
dc.contributor.authorGezmen Karadağ, Makbule
dc.date.accessioned2025-03-13T08:15:00Z
dc.date.available2025-03-13T08:15:00Z
dc.date.issued2025
dc.departmentFakülteler, Sağlık Bilimleri Fakültesi, Beslenme ve Diyetetik Bölümü
dc.description.abstractPurpose of Review: This study aims to analyze the effects of vitamin D on serotonin synthesis, release, and function in the brain, and to explore its relationship with various psychiatric disorders. Recent Findings: The hormone calcitriol plays a vital role in regulating a multitude of biological processes within the human body. Its deficiency can lead to significant adverse effects on overall health and well-being, including physical and psychological consequences. Evidence indicates that vitamin D may exert influences through receptors in the brain, modulating serotonin production and influencing emotional and cognitive processes. Recent studies propose that elevated serum vitamin D may enhance mood and alleviate depressive states. The impact of vitamin D on cognitive function and behavior remains an area of ongoing investigation. This literature review analyses the available evidence on how vitamin D intake impacts the severity of illness and medication requirements in diverse psychiatric disorders. A review of the literature suggests that there may be a correlation between vitamin D and serotonin, which could potentially contribute to more favorable outcomes in the context of illness. Vitamin D may increase the amount of serotonin in the synaptic gap, which is the intended use of selective serotonin reuptake inhibitors (SSRIs), with its effect on the increase in serotonin release. Summary: According to reports, vitamin D supplementation in conjunction with SSRI group medication provides an additive effect for the management of psychiatric disorders.
dc.description.sponsorshipTürkiye Bilimsel ve Teknolojik Araştırma Kurumu (TUBITAK)
dc.identifier.doi10.1007/s13668-025-00630-7
dc.identifier.issn2161-3311
dc.identifier.issue1
dc.identifier.pmid40025236
dc.identifier.scopus2-s2.0-85219592075
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1007/s13668-025-00630-7
dc.identifier.urihttps://hdl.handle.net/11501/2077
dc.identifier.volume14
dc.identifier.wosWOS:001434628500001
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorBostan, Zekiye Zeynep
dc.institutionauthorid0000-0001-9783-0972
dc.language.isoen
dc.publisherSpringer Nature
dc.relation.ispartofCurrent Nutrition Reports
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectMajor Depressive Disorder
dc.subjectNeuropsychiatry
dc.subjectSerotonin
dc.subjectSSRIs
dc.subjectVitamin D
dc.titleCan Vitamin D reduce the need for SSRI by modulating serotonin synthesis? : a review of recent literature
dc.typeReview Article

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Tam Metin / Full Text
Boyut:
710.83 KB
Biçim:
Adobe Portable Document Format
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed to upon submission
Açıklama:
İndir

Koleksiyon

Sağlık Bilimleri Fakültesi Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu